Literature DB >> 10394047

Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms.

N Komatsu1, K Kodama, N Yamanouchi, S Okada, S Noda, Y Nawata, K Takabayashi, I Iwamoto, Y Saito, Y Uchida, H Ito, K Yoshikawa, T Sato.   

Abstract

To determine brain functional abnormality in systemic lupus erythematosus (SLE) patients with psychiatric symptoms, we evaluated 12 active SLE patients with or without psychiatric symptoms by means of [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (PET), magnetic resonance imaging and neuropsychological testing. Patients with psychiatric symptoms showed significantly poorer performance in tests which subserved attentional function. The PET study revealed that the psychiatric patients had significantly decreased regional cerebral metabolic rates for glucose in the prefrontal, inferior parietal and anterior cingulate regions. Prefrontal, inferior parietal and anterior cingulate dysfunction may be related to attentional deficits that are involved in various psychiatric symptoms in SLE. PET is an invaluable tool to reveal such brain functional abnormality seen in SLE patients with psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394047     DOI: 10.1159/000008067

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  13 in total

1.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

3.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

Review 4.  Metabolomics approach in allergic and rheumatic diseases.

Authors:  Rossana Scrivo; Luca Casadei; Mariacristina Valerio; Roberta Priori; Guido Valesini; Cesare Manetti
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

5.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

Review 6.  Neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  David Hermosillo-Romo; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 7.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

Review 8.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

9.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

10.  Regional brain metabolism in a murine systemic lupus erythematosus model.

Authors:  An Vo; Bruce T Volpe; Chris C Tang; Wynne K Schiffer; Czeslawa Kowal; Patricio T Huerta; Aziz M Uluğ; Stephen L Dewey; David Eidelberg; Betty Diamond
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.